113
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluation

Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel

Pages 1627-1631 | Published online: 28 Jul 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dilsa Mizrak Kaya, Kazuto Harada, Yusuke Shimodaira, Fatemeh G. Amlashi, Quan Lin & Jaffer A. Ajani. (2017) Advanced gastric adenocarcinoma: optimizing therapy options. Expert Review of Clinical Pharmacology 10:3, pages 263-271.
Read now
Dexin Zhang & Daiming Fan. (2007) Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Review of Anticancer Therapy 7:10, pages 1369-1378.
Read now

Articles from other publishers (12)

Peijin Li, Suning Li, Hongmei Gu, Qianfeng Lu, Wenjiao Jiang, Xue Pei, Yilin Sun, Hongjiang Xu, Guangji Wang & Kun Hao. (2018) The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing mice. Biomedicine & Pharmacotherapy 97, pages 1000-1010.
Crossref
Tao Liu, Xidong Wu, Yigang Wang, Xiongjun Hou, Gang Jiang, Ting Wu, Huifen Xie & Minqiang Xie. (2017) CD-PLLD co-delivering docetaxel and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy in vivo. Molecular Medicine Reports 16:2, pages 1383-1388.
Crossref
Huai-Qing Luo, Li Han & Yan Jiang. (2014) Meta-analysis of Six Randomized Control Trials of Chemotherapy Plus Anti-HER Monoclonal Antibody for Advanced Gastric and Gastroesophageal Cancer. Asian Pacific Journal of Cancer Prevention 15:13, pages 5343-5348.
Crossref
Eun Kyung Cho, Ji-Young Park, Kyung Hee Lee, Hong Suk Song, Young Joo Min, Yeul Hong Kim & Jin-Hyoung Kang. (2013) Open-label, randomized, single-dose, crossover study to evaluate the pharmacokinetics and safety differences between two docetaxel products, CKD-810 and Taxotere injection, in patients with advanced solid cancer. Cancer Chemotherapy and Pharmacology 73:1, pages 9-16.
Crossref
Lin Hou, Ying Fan, Jing Yao, Jianping Zhou, Caocao Li, Zhengjie Fang & Qiang Zhang. (2011) Low molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acid. Carbohydrate Polymers 86:3, pages 1157-1166.
Crossref
Chenghui Huang, Yaping Li, Peiguo Cao, Zhaoxia Xie & Zhiqiang Qin. (2011) Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 31:4, pages 488-496.
Crossref
Xing-Xing Huang, Cheng-Liang Zhou, Hui Wang, Cheng Chen, Shu-Qin Yu, Qian Xu, Yin-Yan Zhu & Yong Ren. (2011) Pharmacokinetics, Efficacy, and Safety Evaluation of Docetaxel/Hydroxypropyl-Sulfobutyl-β-Cyclodextrin Inclusion Complex. AAPS PharmSciTech 12:2, pages 665-672.
Crossref
Dexin ZhangDaiming Fan. (2010) New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncology 6:4, pages 527-537.
Crossref
Jian Zhang, Zhiyu Qian & Yueqing Gu. (2009) In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel . Nanotechnology 20:32, pages 325102.
Crossref
Takaya Shimura, Hiromi Kataoka, Makoto Sasaki, Tomonori Yamada, Kazuki Hayashi, Shozo Togawa, Fumihiro Okumura, Eiji Kubota, Hirotaka Ohara & Takashi Joh. (2009) Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis. Journal of Gastroenterology and Hepatology 24:8, pages 1358-1364.
Crossref
Tingyan Liu, Meixia Zhang, Hongliang Zhang, Chunyan Sun, Xiaolin Yang, Yihui Deng & Wenyue Ji. (2008) Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer. European Journal of Pharmacology 587:1-3, pages 78-84.
Crossref
Baorui Liu, Mi Yang, Rutian Li, Yitao Ding, Xiaoping Qian, Lixia Yu & Xiqun Jiang. (2008) The antitumor effect of novel docetaxel-loaded thermosensitive micelles. European Journal of Pharmaceutics and Biopharmaceutics 69:2, pages 527-534.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.